Splice-site and Frameshift Mutations of β-Globin Gene Found in Thalassemia Carrier Screening in Yogyakarta Special Region, Indonesia

被引:5
作者
Handayani, Niken Satuti Nur [1 ]
Husna, Nailil [1 ]
Rahmil, Gunawan [1 ]
Ghifari, Riris Anindya [1 ]
Widyawati, Lily [1 ]
Lesmana, Indra [1 ]
机构
[1] Univ Gadjah Mada, Fac Biol, Dept Trop Biol, Jl Teknika Selatan, Sekip Utara, Yogyakarta, Indonesia
关键词
beta-Globin gene; thalassemia; screening; carrier; mutation; Yogyakarta;
D O I
10.18585/inabj.v13i1.1406
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BACKGROUND: beta-thalassemia is an inherited blood disorder that relatively common in Southeast Asian countries. In Indonesia, it is estimated that 200,000 infants with thalassemia carrier born each year. Mutation causing beta-thalassemia is highly varied and relatively specific in a population. This study aimed to identify the mutations responsible for beta-thalassemia from Thalassemia Carrier Screening conducted in Yogyakarta Special Region. This information is beneficial for developing a strategic prevention program to control thalassemia in the region. METHODS: Twenty-eight blood samples of haematologically suspected beta-thalassemia from participant of thalassemia screening program in Yogyakarta Special Region were investigated for beta-globin gene mutation by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), amplification refractory mutation system (ARMS) and DNA sequencing. RESULTS: Our samples showed average HbA2 value of 5 +/- 0.81% and HbF value of 2 +/- 2.29%. It showed eight abnormal erythrocyte morphologies dominated by hypochromia (96.4%), cigar cell (85.7%), and microcytosis (78.6%). Our molecular investigation identified three splice-site mutations namely InterVening Sequence (IVS)-1-5 (G>C) (71.4%), IVS-1-2 (T>C) (7.1%), and IVS-1-1 (G>T) (3.6%), two frameshift mutations that are CD35 (-C) (10.7%) and CD8/9 (+G) (3.6%), and a missense mutation of CD6 (GAG>GTG) (3.6%). CONCLUSION: Our study concluded on a high prevalence of IVS-1-5 (G>C) mutation in Yogyakarta Special Region. This mutation information is significant for developing a strategic prevention program to control thalassemia in the region, for example for developing a rapid molecular test for future screening program.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 22 条
[1]  
[Anonymous], 2015, BIOMED ENG
[2]  
Arif Ahmad Al, 2020, Pak J Biol Sci, V23, P17, DOI 10.3923/pjbs.2020.17.26
[3]   Beta-thalassemia: from genotype to phenotype [J].
Danjou, Fabrice ;
Anni, Franco ;
Galanello, Renzo .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (11) :1573-1575
[4]   Increased knowledge of thalassemia promotes early carrier status examination among medical students [J].
Dewanto, Julius Broto ;
Tansah, Haryono ;
Dewi, Sari Puspa ;
Napitu, Helena ;
Panigoro, Ramdan ;
Sahiratmadja, Edhyana .
UNIVERSA MEDICINA, 2015, 34 (03) :220-228
[5]   Classification of the Disorders of Hemoglobin [J].
Forget, Bernard G. ;
Bunn, H. Franklin .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2013, 3 (02)
[6]  
Fucharoen Suthat, 2011, Indian J Med Res, V134, P498
[7]   Beta-thalassemia [J].
Galanello, Renzo ;
Origa, Raffaella .
ORPHANET JOURNAL OF RARE DISEASES, 2010, 5
[8]  
Hafiza Alauddin, 2012, Malays J Pathol, V34, P161
[9]   Sociocultural challenges of beta-thalassaemia major birth in carriers of beta-thalassaemia in Iran [J].
Haghpanah, Sezaneh ;
Nasirabadi, Shiva ;
Rahimi, Nazila ;
Faramarzi, Hossein ;
Karimi, Mehran .
JOURNAL OF MEDICAL SCREENING, 2012, 19 (03) :109-111
[10]  
Husna N., 2017, J Med Sci, V49, P106